ApoTech Overview

  • Founded
  • 2000

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 2

ApoTech General Information


Operator of a biotechnology company intended to commercialize powerful, small molecule anti-apoptotic technologies. The company's technology is designed to offer a platform for rescue of damaged cells from premature death regardless of the exact cause of dysfunction. It focuses on neurodegenerative pathologies such as Parkinson's Disease (PD), Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Chemotherapy-Induced Neuropathy, Cognitive Decline after Circulatory Arrest (Bypass Dementia) and RNA-Virus Associated Apoptosis.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Primary Industry
Other Industries
Primary Office
  • 4419 West Sevilla Street
  • Tampa, FL 33629
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ApoTech Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ApoTech‘s full profile, request access.

Request a free trial